Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0656
D

Failure to Timely Develop Care Plan for Psychotropic Medication Use

South Bend, Indiana Survey Completed on 06-19-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to develop and implement a comprehensive care plan in a timely manner for a resident who was prescribed an anti-anxiety medication, Ativan, to be administered prior to dialysis sessions. The resident had multiple diagnoses, including Alzheimer's disease, vascular dementia, chronic kidney disease, and adjustment disorder with anxiety. The order for Ativan was given by the Psychiatric Nurse Practitioner following a request from the Memory Care Director, and the medication was administered regularly as prescribed. However, review of the resident's clinical record and care plans revealed that a care plan addressing the use of Ativan for anxiety was not initiated until over two months after the medication was started. Interviews with facility staff, including the Assistant Director of Nursing and the Director of Nursing, confirmed that a care plan should have been created immediately after the Ativan was ordered, but this was not done. The facility's policy on psychotropic management requires that symptoms and therapeutic goals be documented prior to initiating such medications, and that care plans be developed to promote the resident's highest practicable well-being. The lack of a timely care plan for the use of Ativan constituted a failure to meet these requirements.

An unhandled error has occurred. Reload 🗙